About this Webinar
During this webinar, our analysts review the incorporation of ESG metrics in pharmaceutical pricing, tendering and market access, including increasing visibility as a key topic among ESG investors.
The webinar will last approximately 60 minutes and will cover:
-How investors have started incorporating pharmaceutical pricing as an ESG metric
-Reforms around the world which are incorporating ESG criteria which impact pharma market access
-Impact on pharma market access and pricing strategies
Speakers
Gustav Ando
Gustav oversees GlobalData’s healthcare economics and market access group, which includes data, analytics, research, consulting and commercial divisions, and is responsible for devising its growth and overall product strategy. Prior to overseeing the sale of this business to GlobalData in 2021, Gustav spent 18 years with IHS Markit and its predecessor companies in a number of leadership roles across different industry vertical groups. He has spent the bulk of his career supporting the life sciences sector, launching a series of health economic and pricing & reimbursement (P&R) capabilities that included the world’s first specialised global P&R product, PharmOnline International (POLI).
Eoin Ryan
Eoin leads the European team of healthcare and pharma research analysts at GlobalData, producing critical intelligence to pharma companies shaping their strategic planning and market access strategies. This includes daily analysis, country reports and strategic reports, as well as leveraging critical proprietary datasets to provide unique insights, particularly on market access and P&R themes. He holds a Master of Arts degree in International Relations from University College Dublin and a Master of Science degree in Health Policy and Economics from the London School of Economics. Prior to joining Life Sciences, Eoin worked with the Economics and Country Risk team at GlobalData. His areas of expertise include pharmaceutical regulation and healthcare policy
Rachel Foster Jones
Rachel Foster Jones joined GlobalData in September 2021 as an analyst in the Themes group. In this role, she is responsible for managing and updating GlobalData’s cross-sector analysis on disruptive innovations that will drive macroeconomic shifts, technologies and social trends over the next five years. She has a specific focus on ESG. She has previously worked as an environmental researcher at the ESG Foundation. Rachel completed her BA in Biological Sciences at University of Oxford and her MSc in Environmental Technology at Imperial College London.
Past Webinars
View more past webinarsUpcoming Webinars
View more upcoming webinarsSearch companies, themes, reports, as well as actionable data & insights spanning 22 global industries
Access more premium companies when you subscribe to Explorer


